Recent studies have indicated that approximately 50% of hepatocellular carcinoma cases display aberrant PI3K‐AKT and Wnt‐β‐catenin signalling pathways, respectively.21 Meng et al. This evidence concerns the gene AKT1 and hepatocellular carcinoma.